Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd9bd3d0ef4ab6462999763038943d0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d081a5cf90f826b63df8f0f340d4972 |
publicationDate |
2008-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008200505-A1 |
titleOfInvention |
Piperidines for the Treatment of Chemokine Mediated Diseases |
abstract |
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016271112-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828284-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9468630-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015061777-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11026928-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612589-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10383856-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10383857-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751328-B2 |
priorityDate |
2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |